Your browser doesn't support javascript.
loading
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Vaklavas, Christos; Stringer-Reasor, Erica M; Elkhanany, Ahmed M; Ryan, Kevin J; Li, Yufeng; Theuer, Charles P; Acosta, Edward P; Wei, Shi; Yang, Eddy S; Grizzle, William E; Forero-Torres, Andres.
  • Vaklavas C; Huntsman Cancer Institute of the University of Utah, 2000 Circle of Hope, RS2509, Salt Lake, UT, 84112, USA. christos.vaklavas@hci.utah.edu.
  • Stringer-Reasor EM; University of Alabama at Birmingham, Birmingham, AL, USA. christos.vaklavas@hci.utah.edu.
  • Elkhanany AM; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Ryan KJ; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Li Y; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Theuer CP; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Acosta EP; TRACON Pharmaceuticals, San Diego, CA, USA.
  • Wei S; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Yang ES; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Grizzle WE; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL, USA.
Breast Cancer Res Treat ; 198(2): 217-229, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36735117
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article